000 | 01626 a2200493 4500 | ||
---|---|---|---|
005 | 20250513205902.0 | ||
264 | 0 | _c20000502 | |
008 | 200005s 0 0 ita d | ||
022 | _a0026-4784 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKatsaros, D | |
245 | 0 | 0 |
_a[Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]. _h[electronic resource] |
260 |
_bMinerva ginecologica _cDec 1999 |
||
300 |
_a463-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xbiosynthesis |
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xbiosynthesis |
650 | 0 | 4 | _aDrug Resistance, Multiple |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenes, MDR |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aMembrane Transport Proteins |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
650 | 0 | 4 | _aMultidrug Resistance-Associated Proteins |
650 | 0 | 4 |
_aNeoplasm Proteins _xbiosynthesis |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aVault Ribonucleoprotein Particles _xbiosynthesis |
700 | 1 | _aFracchioli, S | |
700 | 1 | _aArts, H J | |
700 | 1 | _ade Vries, E G | |
700 | 1 | _aDanese, S | |
700 | 1 | _aRichiardi, G | |
700 | 1 | _aArisio, R | |
700 | 1 | _aGordini, G | |
700 | 1 | _aVan der Zee, A G | |
700 | 1 | _aSuurmeijer, A J | |
700 | 1 | _aMassobrio, M | |
773 | 0 |
_tMinerva ginecologica _gvol. 51 _gno. 12 _gp. 463-70 |
|
999 |
_c10721147 _d10721147 |